Neointimal formation at the sites of anastomosis of the internal thoracic artery grafts after coronary artery bypass grafting in human subjects: An immunohistochemical analysis  by Hosono, Mitsuharu et al.
sion of the ITA graft.4,5 Previous clinical studies have
revealed that ITA stenosis commonly occurs at the site of
anastomosis4-8 and generally develops within 3 months
after the operation.8 Shimshak and colleagues6 suggested
that on the basis of angiographic appearance and the inter-
val from surgery, intimal hyperplasia appears to be
responsible for anastomotic stenosis in ITA grafts. To the
best of our knowledge, however, no systematic studies
have focused on histologic and immunohistochemical
characteristics of the anastomotic sites of ITA grafts at
early stages after CABG in human subjects. The present
study examined these characteristics.
Material and methods
Materials. This study is based on 7 ITA grafts obtained at
autopsy from 7 patients who had undergone CABG with an in
situ ITA graft but who died within 92 days after the operation.
The internal thoracic artery (ITA) as a conduit for coro-nary artery bypass grafting (CABG) has proved to be
superior to the saphenous vein graft.1-3 Although the
majority of ITA grafts achieve long-term patency, there is
still the occasional patient who shows stenosis or occlu-
Objectives: The aim of this study was to evaluate the cellular composition
and cell proliferative activity of neointimal tissue in human internal thoracic
artery grafts and to characterize the differentiation state of neointimal
smooth muscle cells at early stages after coronary artery bypass grafting.
Methods: The anastomotic sites and body segments of 7 patent grafts were
obtained at autopsy from 7 patients who died within 92 days after operation.
Serial sections were examined by immunohistochemical techniques to iden-
tify macrophages, endothelial cells, smooth muscle cell phenotype, and pro-
liferating cells. For the identification of the cell types that show cell prolif-
erative activity, immunodouble staining was also performed.
Results: In all body segments the luminal surface was completely covered by
endothelial cells, and no areas showed thrombus formation or neointimal pro-
liferation after grafting. In contrast, in the anastomotic segments endothelial
denudation and focal disruption of the internal elastic lamina with adherence of
fibrin-platelet thrombus and infiltration of macrophages were observed in the
earliest stage after grafting. At these sites of injury, early neointimal tissue
response had occurred, and cell proliferative activity was detected in
macrophages and dedifferentiated smooth muscle cells. During the evolution of
neointimal thickening, redifferentiation of neointimal smooth muscle cells
occurred associated with the decline in proliferative activity.
Conclusions: These observations strongly support the concept that excessive
neointimal proliferation, which may occur at the site of anastomosis because
of extensive damage to the arterial wall, could be one of the possible causes
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All ITA grafts were patent. Table I gives the relevant clinical
data. The interval between CABG and death ranged from 8
hours to 92 days. The causes of death of these patients were
cardiac failure, rupture of abdominal aortic aneurysm, medi-
astinitis, pneumonia, and renal failure. In patient 3 the medi-
astinitis did not involve the ITA area. All ITA–coronary artery
anastomoses were constructed in an end-to-side fashion with
continuous 8-0 monofilament sutures.
Fifteen nonimplanted ITA segments, harvested at surgery,
were also studied as controls.
Methods. The post-CABG heart specimens and normal
ITA segments were fixed in methanol-Carnoy fixative (60%
methanol, 30% chloroform, and 10% glacial acetic acid).
This method of fixation has the advantage that the immuno-
histochemical investigations necessary for this study can be
performed on paraffin-embedded sections.
The ITA grafts, together with the left anterior descending
arteries, which contained the sites of anastomosis, were
removed from the epicardial surface. The anastomotic sites
were cut serially at 2-mm intervals perpendicular to the
long axis, and two slices from each anastomotic site were
obtained (slices from anastomotic sites, n = 14). The bod-
ies of the grafts were also cut serially at 5-mm intervals,
and 10 slices from each body segment were obtained (slices
from body segments, n = 70). Then a total number of 84
slices from both anastomotic and body segments of the ITA
grafts were examined.
All slices obtained from the ITA grafts and from control
segments were processed routinely and embedded in paraffin.
From each slice, 20 serial sections were cut at a thickness of
5 µm. Every first and second section was stained with con-
ventional hematoxylin-eosin and Weigert elastic–van Gieson
stain, respectively. The other sections were used for immuno-
histochemical staining.
Immunohistochemistry. The primary monoclonal anti-
bodies used for the identification of smooth muscle cells
(SMCs) were the anti-SMC actin markers HHF-35 and CGA-
7. For endothelial cell identification, an anti–von Willebrand
factor (vWf) antibody was used. HAM-56 and PGM-1 were
used for the identification of macrophages. An anti-vimentin
monoclonal antibody was used to identify mesenchymal
cells. A monoclonal antibody to proliferating cell nuclear
antigen (PCNA) was used to detect proliferating cells. The
source, specification, and working dilution of the antibodies
used are summarized in Table II.9-11
Single staining. Sections were incubated with the primary
antibodies for 1 hour at room temperature. The labeled strep-
tavidin-biotin complex system with nickel chloride color
modification was performed in all instances. Sections were
counterstained with methyl green.
Evaluation of phenotypic differentiation of SMCs. In this
study the differentiation state of SMCs was evaluated by use
of two anti-actin markers, HHF-35 and CGA-7, according to
our previous studies.12-14 Highly differentiated SMCs stain
positive with both HHF-35 and CGA-7, whereas dedifferen-
tiated SMCs stain negative with both HHF-35 and CGA-7,
and intermediately differentiated SMCs stain positive with
HHF-35 but negative with CGA-7.
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Table I.  Relevant clinical data
Case Age Reason for Site of Interval Cause of
No. (y) Sex CABG anastomosis CABG-death death Coronary risk factors
1 68 F AMI LAD 8 h Cardiac failure Hypercholesterolemia
2 74 F UAP LAD 2 d Rupture of AAA Hypercholesterolemia
3 64 M UAP LAD 7 d Mediastinitis Smoking
4 72 M UAP LAD 19 d Cardiac failure Smoking
5 61 M AMI LAD 23 d Pneumonia Gout, smoking
6 56 M UAP LAD 56 d Cardiac failure Diabetes mellitus, gout
7 73 M AMI LAD 92 d Renal failure Hypercholesterolemia, diabetes mellitus, smoking
AMI, Acute myocardial infarction; LAD, left anterior descending artery; UAP, unstable angina pectoris; AAA, abdominal aortic aneurysm.
Table II.  Monoclonal antibodies used in the study
Working
Antibody Specificity and reactivity Reference Source in dilution
HHF-35 Muscle actin Gown et al9; Tsukada et al10 Dako 1:50
CGA-7 Smooth muscle cell actin Gown et al9; Gown et al11 Enzo 1:20
Anti-vimentin Smooth muscle cells, fibroblasts, macrophages, endothelial cells Dako 1:70
HAM-56 Macrophages, some endothelial cells Gown et al9 Dako 1:70
PGM-1 Macrophages Dako 1:100
Anti-vWf Endothelial cells Dako 1:50
Anti-PCNA Proliferating cells Dako 1:50
Antibodies were obtained from Dako A/S (Glostrup, Denmark) and Enzo Biochemicals, Inc (New York, NY).
Immunodouble staining. For the simultaneous identifica-
tion of SMCs and macrophages, sections were double-stained
with HHF-35 and HAM-56, according to procedures previ-
ously reported.15 In this immunodouble staining, we visual-
ized the enzymatic activity of β-galactosidase for HHF-35 in
turquoise (BioGenex Kit, San Ramon) and the activity of
alkaline phosphatase for HAM-56 in red (New Fuchsin Kit,
Dako).
To evaluate the differentiation state of SMCs in relation to
PCNA positivity, we also performed immunodouble staining
for SMC actin (HHF-35) and PCNA. In this staining, alkaline
phosphatase was visualized with fast blue BB (blue, HHF-35)
and peroxidase with 3-amino-9-ethylcarbazole development
(red, PCNA).
Results
Normal ITA segments. Six of the 15 normal ITA
segments showed low-grade pre-existent intima with
abundant elastic fibers, but none revealed atheroscle-
rotic changes.
Immunohistochemically, the pre-existent intima of
these normal ITA specimens contained abundant
SMCs, and these intimal SMCs stained positive with
both actin markers, HHF-35 and CGA-7, indicating
that the intimal SMCs were highly differentiated. The
media also consisted of highly differentiated SMCs.
Some macrophages were scattered in the adventitia, but
no macrophages were found in the media or pre-exis-
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Fig 1. Micrographs of a body segment 2 days after grafting. Panels A-E represent serial sections. A, Elastic tissue
stain. No injuries are seen in the arterial wall. B, Staining with anti-vWf. The luminal surface is completely cov-
ered by vWf-positive endothelial cells. C, Staining with HHF-35. SMCs in the media are positive with HHF-35.
D, Staining with CGA-7. SMCs in the media are also positive with CGA-7, indicating that these SMCs are highly
differentiated. E, Staining with HAM-56. Scattered macrophages are found in the adventitia, but no macrophages
are present in the media. (Original magnification 64×.)
tent intima. There were no PCNA-positive cells in the
normal ITA segment.
ITA grafts after CABG at the body segments.
Immunohistochemical studies demonstrated that in all
body segments examined the luminal surface was com-
pletely covered by vWf-positive endothelial cells (Fig
1, A and B). SMCs within the media revealed charac-
teristic features of a highly differentiated state (Fig 1, C
and D), and no or only occasional macrophages were
present in the media (Fig 1, E). In these body segments
no areas showed formation of fibrin-platelet thrombus
or neointimal proliferation after CABG, and no PCNA-
positive cells were observed.
ITA grafts after CABG at the sites of anastomosis.
All slices obtained from anastomotic sites revealed
CABG-related pathologic changes. At similar time inter-
vals, the CABG-related pathologic changes observed
were remarkably similar. This thus allowed a collective
description of the findings for each stage after CABG.
Injury and cellular response. At the earliest stage,
less than 2 days after CABG (patients 1 and 2), the
histopathologic and immunohistochemical features of
the ITA grafts at the sites of anastomosis were charac-
terized by endothelial denudation and focal disruptions
of the internal elastic lamina with fibrin-platelet throm-
bus and infiltration of macrophages (Fig 2).
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Fig 2. Micrographs of an anastomotic site 2 days after grafting. Panels A and B are serial sections. A,
Hematoxylin-eosin stain. Adherence of fibrin-platelet thrombus (T) is seen at the site of endothelial denudation and
focal disruption of the internal elastic lamina of an ITA. CA, Coronary artery. B, Staining with HAM-56. Distinct
infiltration of macrophages is present at the site of anastomotic injury. T, Fibrin-platelet thrombus. (Original mag-
nification 86×.)
From 7 days onward (patients 3, 4, 5, 6, and 7), the anas-
tomotic sites showed a distinct layer of neointimal tissue,
albeit to varying degrees (Fig 3). Immunodouble staining
for macrophages and SMCs revealed that at earlier stages
(7, 19, and 23 days after CABG) the neointima was
accompanied by distinct accumulation of macrophages
(Fig 4, A and B), whereas at later stages (56 and 92 days
after CABG) no or only occasional macrophages were
identified within the neointima (Fig 4, C and D).
Cell proliferation at the site of injury. At the ear-
liest stage after CABG, occasional PCNA-positive
cells were found in the media. From 7 to 23 days
after CABG, PCNA positivity was detected in both
the media and neointimal tissue. Immunodouble
staining for PCNA and SMC actin (HHF-35)
revealed that PCNA-positive cells in these neointimal
tissues were actin (HHF-35) negative dedifferentiat-
ed SMCs and macrophages (Fig 5, A and B).
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Fig 3. Micrographs showing neointimal tissue formation at the anastomotic sites at different time intervals after
grafting. Elastic tissue stain. A, At 19 days, early neointimal tissue (N) is seen. B, At 56 days, a more prominent
neointima (N) is found. (Original magnification 129×.)
PCNA positivity within the neointima diminished
with time, and from 56 days onward, no PCNA-posi-
tive cells were observed (Fig 5, C and D).
Differentiation states of SMCs within the neointi-
ma. At 7 days, the neointimal tissue was composed of
macrophages and spindle-shaped cells. Immunohisto-
chemically, the majority of the spindle-shaped cells in
the neointima were vimentin positive, HHF-35 nega-
tive, and CGA-7 negative, indicating that these spindle-
shaped cells were dedifferentiated SMCs.
At stages 19 days and 23 days after CABG, most
spindle-shaped cells in the neointima became positive
with HHF-35 and showed immunohistochemical char-
acteristics of intermediately differentiated SMCs.
From 56 days onward, almost all spindle-shaped cells
within the neointima stained positive with both HHF-
35 and CGA-7, indicating that these cells were highly
differentiated SMCs (Fig 6).
Endothelial cell recovery. From 7 to 23 days, no
vWf-positive endothelial cells covering the neointimal
tissue were found. However, from 56 days onward, a
regenerated endothelial layer was observed at the lumi-
nal surface of the neointima.
Discussion
Previous studies have reported that ITA graft stenosis
tends to occur early after operation, particularly at the
sites of anastomosis.4-8 However, the pathologic changes
at the sites of anastomosis of the ITA grafts after CABG
have been little studied. To the best of our knowledge,
this is the first study to demonstrate biologic processes of
neointimal tissue proliferation by immunohistochemical
techniques in human ITA grafts at sites of anastomosis at
early stages and up to 92 days after CABG.
The present study revealed that in human ITA grafts at
the earliest stage after CABG, endothelial denudation
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Fig 4. Micrographs showing the cellular composition of neointimal tissue at different time intervals after grafting.
Immunodouble staining for macrophages (red) and SMCs (turquoise). A, At 19 days, neointimal tissue is composed
of macrophages (red) and SMCs (turquoise). B, At 23 days, abundant macrophages (red) are present in the neoin-
tima. C, At 56 days, neointimal tissue is composed mainly of SMCs (turquoise) with only occasional macrophages
(red). D, At 92 days, neointimal tissue consists almost entirely of SMCs (turquoise). (Original magnification 404×.)
with adherence of fibrin-platelet thrombus and focal dis-
ruption of the internal elastic lamina were found only in
the anastomotic segments and not in the body segments.
Moreover, immunohistochemical investigations clearly
showed that the endothelial cell lining in the body seg-
ments was well retained after CABG. At later stages,
neointimal tissue response was limited to the injured
areas of the anastomotic sites, but no neointimal thicken-
ing was found in any segments of the body. In previous
postmortem histologic studies, body segments of the ITA
grafts after CABG showed no or only mild neointimal
thickening.16,17 Our findings for the body segments are
consistent with these previous reports. Moreover, the pre-
sent study, with immunohistochemical techniques, pro-
vides further support for the hypothesis that retention of
endothelial cell lining in the body segments is a major
contributing factor to excellent long-term patency rates
for ITA grafts after CABG.
It is widely believed that the construction of anasto-
mosis causes focal damage to the arterial wall, which is
subsequently repaired by neointimal tissue response;
this concept is inferred largely from findings in experi-
mental animals.18-23 To date, in human ITA grafts
detailed characterization of anastomotic neointimal
thickening is lacking. The present immunohistochemi-
cal study provides new findings on the nature of the
cellular mechanisms that underlie neointimal thicken-
ing at the sites of anastomosis in human ITA grafts.
This study revealed endothelial denudation with depo-
sition of fibrin-platelet thrombus and infiltration of
macrophages at the anastomotic sites at the earliest
stage examined less than 2 days after CABG. Our
immunohistochemical investigation, using immuno-
double staining techniques with SMCs and mac-
rophages, also found that at subsequent stages (7-23
days after CABG) macrophage infiltration within the
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Fig 5. Micrographs showing cell proliferative activity of neointimal tissue at different time intervals after grafting.
Immunodouble staining for PCNA (red) and SMC actin (blue). A, At 19 days, both actin-negative dedifferentiated
SMCs (arrows) and macrophages in the neointima show PCNA positivity (compared with Fig 4, A). B, At 23 days,
PCNA positivity is found in dedifferentiated SMCs (arrows) and macrophages in the neointima (compared with
Fig 4, B). C, At 56 days, there are no PCNA-positive cells in the neointima. D, At 92 days, no PCNA-positive cells
are seen in the neointima. (Original magnification 539×.)
neointima occurred transiently. These data strongly
suggest that the initial endothelial denudation with
adherence of fibrin-platelet thrombus and the infiltra-
tion of macrophages are key events in the early stage of
neointimal proliferation. Recent in vitro studies have
suggested that platelet thrombus and macrophages
secrete a variety of cytokines and growth factors that
are important in SMC proliferation and chemo-
taxis.24,25 These experimental data and our present
findings support the hypothesis that release of such fac-
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Fig 6. Micrographs showing redifferentiation of SMCs within the neointima 56 days after grafting. A, Staining with
HHF-35. Almost all spindle-shaped cells within the neointima (N) are positive with HHF-35. B, Staining with
CGA-7. These cells in the neointima (N) also stain positive with CGA-7, indicating that these cells are highly dif-
ferentiated SMCs. (Original magnification 322×.)
tors from platelets and macrophages promotes SMC
proliferation and migration in the process of neointimal
formation at the anastomotic site of the ITA graft after
CABG in human subjects.
Previous experimental work in animal models after
vascular injury has shown that redifferentiation of
SMCs occurs during the evolution of neointimal thick-
ening, as revealed by changes in the expression of
cytoskeletal proteins.13,26,27 Our previous studies in
human coronary arteries after percutaneous translumi-
nal coronary angioplasty also demonstrated a similar
shift in the cytoskeletal phenotype of neointimal
SMCs.12,28 The present study, for the first time, pro-
vides evidence that redifferentiation of SMCs occurs as
part of the evolution of neointimal thickening at the
anastomotic sites in human ITA grafts.
This study also provides new data with regard to cell
proliferative activity related to anastomotic injury in
human ITA grafts. At early stages after CABG, cell
proliferative activity was identified in both the media
and neointima at the sites of anastomosis. In the latter,
both macrophages and dedifferentiated SMCs showed
cell proliferation. However, at later stages from 56 days
onward, proliferative activity could no longer be
detected within the neointima; at these stages, the
neointima consisted predominantly of highly differen-
tiated SMCs. These observations suggest that the
decline in cell proliferative activity during the evolu-
tion of the neointima is related to the redifferentiation
of neointimal SMCs. This concept is supported by pre-
vious experimental studies of neointimal cellular kinet-
ics and phenotypic changes of SMCs.13,26,27 In human
subjects, however, there is only scant evidence of cell
proliferation as part of the process of neointimal for-
mation. O’Brien and colleagues,29 using an antibody
against PCNA to examine cell proliferation in atherec-
tomy specimens obtained from human coronary
restenotic lesions after angioplasty, found that cell pro-
liferation occurred infrequently and at low levels in
these specimens. The differences between our observa-
tions and those reported by O’Brien and colleagues
may be related to differences in tissue characteristics or
to differences in time factors. In our study PCNA pos-
itivity was found frequently only in the early stages
after CABG, and it is unlikely that the restenotic
lesions observed by O’Brien and colleagues are similar
to our materials. In our materials, moreover, immuno-
double staining for PCNA and SMC actin revealed dis-
tinct PCNA positivity in dedifferentiated SMCs. These
observations strongly suggest that a close relationship
between SMC dedifferentiation and enhanced prolifer-
ative activity is present in human ITA grafts at the early
stages after anastomotic injury.
Clinical implications. Our study documented that
endothelial injuries and focal disruption of the internal
elastic lamina with adherence of fibrin-platelet thrombus
and infiltration of macrophages are the most prominent
changes in the earliest stage after CABG of the anasto-
motic sites of human ITA grafts. These observations
strongly suggest that mural thrombosis with macrophage
infiltration triggers the healing process, which may even-
tually lead to anastomotic neointimal thickening. Indeed,
platelet adherence and aggregation promote the subse-
quent healing process through the release of growth fac-
tors.22,23 Pharmacologic intervention at the very early
stage after CABG (eg, suppression of the aggregation of
platelets at sites of anastomotic injury by using inhibitors
of platelet glycoprotein IIb/IIIa receptor) can therefore be
recommended, although this treatment may possibly
increase bleeding complications if these substances are
given systemically.
Failure of the ITA grafts early after CABG is not fre-
quent, and therefore the nature of early occlusive
changes at the site of anastomosis has not been com-
pletely defined. Some possible causes have been sug-
gested: technical faults, thrombosis, or intimal hyper-
plasia.4 Our present findings strongly suggest that
excessive neointimal proliferation, which may occur at
the site of anastomosis as a result of extensive damages
to the arterial wall, could be one of the possible causes
of failure of the ITA grafts in human subjects.
Study limitations. It is extremely difficult to acquire
suitable ITA grafts from autopsied cases for reliable
immunohistochemical studies. With respect to the
attempt to represent a time-related sequence of events
after anastomotic injuries in human ITA grafts after
CABG, the main limitation is the small number of autop-
sied cases studied. Nevertheless, our findings are intrigu-
ing because experimental angioplasty injuries and human
coronary arteries after angioplasty have shown similar
pathologic processes of neointimal thickening.
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